Lung Cancer Researchers Identify Gene Set That Shows Which Patients Benefit from Chemotherapy After Surgery

Lung cancer researchers have identified a genetic signature that can help doctors determine which patients with early-stage non-small cell lung cancer are at high risk for developing disease recurrence and therefore may benefit from chemotherapy after surgery ("adjuvant chemotherapy").

Read the whole article on Newswise - Scinews

More from Newswise - Scinews